-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
rac α-Lipoic Acid-[d5]
Category | Human immunodeficiency Virus (HIV) |
CAS | 1189471-66-6 |
Description | rac α-Lipoic Acid-[d5] is the labelled analogue of rac α-Lipoic Acid, which is a fat-metabolism stimulator. |
Product Information
Synonyms | Alpha Lipoic acid-d5; rac α-Lipoic Acid-d5; (+/-)-1,2-Dithiolane-3-pentanoic Acid-d5; (+/-)-1,2-Dithiolane-3-valeric Acid-d5; (+/-)-Thioctic Acid-d5; (RS)-α-Lipoic Acid-d5; DL-Thioctic Acid-d5; Liposan-d5; Lipothion-d5; NSC 628502-d5; NSC 90788-d5; Protogen A-d5; Thioctsan-d5; Tioctacid-d5 |
IUPAC Name | 5,5-dideuterio-5-(3,4,4-trideuteriodithiolan-3-yl)pentanoic acid |
Molecular Weight | 211.35 |
Molecular Formula | C8H9D5O2S2 |
Canonical SMILES | C1CSSC1CCCCC(=O)O |
InChI | InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/i3D2,5D2,7D |
InChIKey | AGBQKNBQESQNJD-KEDGJJNOSA-N |
Boiling Point | 362.5±11.0 °C at 760 mmHg |
Melting Point | 58-61°C |
Flash Point | 173.0±19.3 °C |
Purity | ≥96% by HPLC; 99% atom D |
Density | 1.2±0.1 g/cm3 |
Solubility | Soluble in Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
Appearance | Pale Yellow to Light Yellow Solid |
Storage | Store at -20°C under inert atmosphere |
Index Of Refraction | 1.562 |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
PSA | 87.90000 |
Target | NF-κB; HIV; Mitochondrial Metabolism; Endogenous Metabolite; Apoptosis |
Vapor Pressure | 0.0±1.7 mmHg at 25°C |